ADAM17 and diabetic kidney disease: Guo et al. investigate how Sirt1 activation can prevent the ACE2 downregulation by modulating the TIMP3/ADAM17 pathway in renal tubular cells under high-glucose conditions, which helps maintain ACE2 activity, crucial for renal protection in diabetic kidney disease [59].